Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice
Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Ken‐ichi Hirata, Masataka Sata
Topics & Concepts
EmpagliflozinEndocrinologyInternal medicineInflammationEndothelial dysfunctionApolipoprotein EMedicineDiabetes mellitusType 2 diabetesDiseaseCardiovascular Disease and AdiposityAtherosclerosis and Cardiovascular DiseasesAdipokines, Inflammation, and Metabolic Diseases